RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 59 filers reported holding RENEO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,255 | +132.2% | 1,478 | +100.0% | 0.00% | – |
| Q2 2023 | $4,848 | +32220.0% | 739 | -70.2% | 0.00% | – |
| Q1 2023 | $15 | +7.1% | 2,476 | -58.2% | 0.00% | -100.0% |
| Q4 2022 | $14 | -99.5% | 5,918 | +359.1% | 0.00% | – |
| Q2 2022 | $3,000 | -89.7% | 1,289 | -86.8% | 0.00% | – |
| Q1 2022 | $29,000 | +163.6% | 9,800 | +691.0% | 0.00% | – |
| Q4 2021 | $11,000 | +10.0% | 1,239 | -4.3% | 0.00% | – |
| Q3 2021 | $10,000 | – | 1,295 | +2843.2% | 0.00% | – |
| Q2 2021 | $0 | – | 44 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $8,071,000 | 9.37% |
| Abingworth LLP | 2,073,957 | $6,948,000 | 2.38% |
| Aisling Capital Management LP | 886,075 | $2,968,000 | 1.97% |
| NEA Management Company, LLC | 4,786,921 | $16,036,000 | 0.80% |
| Novo Holdings A/S | 3,430,377 | $11,492,000 | 0.55% |
| Ikarian Capital, LLC | 155,819 | $521,000 | 0.10% |
| Rock Springs Capital Management LP | 1,143,185 | $3,830,000 | 0.10% |
| Ergoteles LLC | 37,640 | $126,000 | 0.00% |
| MAI Capital Management | 63,210 | $212,000 | 0.00% |
| RBF Capital, LLC | 14,536 | $49,000 | 0.00% |